Steven Hyosig Lee
CIK: 0001855708
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BHC
Bausch Health Companies Inc.
Officer
Discretionary Trading P&L
Holdings
About LEE STEVEN HYOSIG
LEE STEVEN HYOSIG (SEC CIK 0001855708) files insider reports with the SEC as SVP, Controller & CAO of Bausch Health Companies Inc. (BHC).
Signal8 holds 4 ownership filings by LEE STEVEN HYOSIG (1 Form 3, 3 Form 4), filed between Jul 15, 2025 and Jul 15, 2026. Those filings report 3 transactions, from Jul 14, 2025 to Jul 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on LEE STEVEN HYOSIG's filings is in BRIDGEWATER, NJ.
Recent filings by LEE STEVEN HYOSIG
Other insiders filing for Bausch Health Companies Inc. (BHC)
- Paulson John, Director
- LEUNG SANDRA, Director
- WECHSLER AMY B, Director
- Lenar Aimee J., President, US Pharma
- ROBERTS EIRY, Director
- POWER ROBERT N, Director